News

Adults with cancer in the U.S. gained 14 million years of life from 40 years of NCTN trials.

Forty years of publicly funded trials added 14 million years of life for cancer patients and profoundly affected cancer care guidelines

A blood serum test can identify which patients have slow-growing disease that might be controlled with an aromatase inhibitor alone.

SWOG has a new executive officer for international affairs and a new melanoma committee chair

Lung-MAP was the NCI's first precision medicine master protocol -- the first of many